Privia Health Group, Inc. (PRVA)
PRVA Stock Price Chart
Explore Privia Health Group, Inc. interactive price chart. Choose custom timeframes to analyze PRVA price movements and trends.
PRVA Company Profile
Discover essential business fundamentals and corporate details for Privia Health Group, Inc. (PRVA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
28 Apr 2021
Employees
1.14k
Website
https://www.priviahealth.comCEO
Parth Mehrotra
Description
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.
PRVA Financial Timeline
Browse a chronological timeline of Privia Health Group, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is $0.08, while revenue estimate is $597.76m.
Earnings released on 7 May 2026
EPS came in at $0.02 falling short of the estimated $0.08 by -75.00%, while revenue for the quarter reached $603.85m , beating expectations by +7.64%.
Earnings released on 26 Feb 2026
EPS came in at $0.07 surpassing the estimated $0.04 by +75.00%, while revenue for the quarter reached $541.17m , beating expectations by +4.85%.
Earnings released on 6 Nov 2025
EPS came in at $0.05 falling short of the estimated $0.06 by -16.67%, while revenue for the quarter reached $580.42m , beating expectations by +12.35%.
Earnings released on 7 Aug 2025
EPS came in at $0.02 falling short of the estimated $0.05 by -60.00%, while revenue for the quarter reached $521.15m , beating expectations by +7.33%.
Earnings released on 8 May 2025
EPS came in at $0.03 falling short of the estimated $0.06 by -50.00%, while revenue for the quarter reached $480.10m , beating expectations by +4.69%.
Earnings released on 27 Feb 2025
EPS came in at $0.03 falling short of the estimated $0.05 by -40.00%, while revenue for the quarter reached $460.90m , missing expectations by -4.08%.
Earnings released on 7 Nov 2024
EPS came in at $0.03 falling short of the estimated $0.05 by -40.00%, while revenue for the quarter reached $437.92m , beating expectations by +4.14%.
Earnings released on 8 Aug 2024
EPS came in at $0.03 falling short of the estimated $0.05 by -40.00%, while revenue for the quarter reached $422.33m , missing expectations by -40.22%.
Earnings released on 9 May 2024
EPS came in at $0.02 falling short of the estimated $0.05 by -60.00%, while revenue for the quarter reached $415.24m , missing expectations by -41.03%.
Earnings released on 27 Feb 2024
EPS came in at $0.02 falling short of the estimated $0.04 by -52.73%, while revenue for the quarter reached $440.83m , missing expectations by -39.69%.
Earnings released on 3 Nov 2023
EPS came in at $0.05 matching the estimated $0.05, while revenue for the quarter reached $417.28m , missing expectations by -42.94%.
Earnings released on 3 Aug 2023
EPS came in at $0.06 matching the estimated $0.06, while revenue for the quarter reached $413.35m , missing expectations by -39.74%.
Earnings released on 4 May 2023
EPS came in at $0.06 surpassing the estimated $0.02 by +228.77%, while revenue for the quarter reached $386.28m , missing expectations by -40.84%.
Earnings released on 28 Feb 2023
EPS came in at $0.14 surpassing the estimated $0.02 by +606.36%, while revenue for the quarter reached $364.42m , missing expectations by -44.19%.
Earnings released on 10 Nov 2022
EPS came in at $0.01 surpassing the estimated $0.00 by +109.21%, while revenue for the quarter reached $342.90m , beating expectations by +7.76%.
Earnings released on 11 Aug 2022
EPS came in at -$0.10 falling short of the estimated -$0.01 by -636.38%, while revenue for the quarter reached $335.54m , beating expectations by +7.09%.
Earnings released on 12 May 2022
EPS came in at $0.12 surpassing the estimated -$0.05 by +340.43%, while revenue for the quarter reached $313.80m , beating expectations by +6.33%.
Earnings released on 22 Mar 2022
EPS came in at $0.06 surpassing the estimated -$0.11 by +154.55%, while revenue for the quarter reached $275.33m , beating expectations by +21.78%.
Earnings released on 8 Nov 2021
EPS came in at $0.13 surpassing the estimated -$0.09 by +244.44%, while revenue for the quarter reached $251.52m , beating expectations by +16.90%.
Earnings released on 9 Aug 2021
EPS came in at $0.09 surpassing the estimated -$1.66 by +105.42%, while revenue for the quarter reached $225.76m , beating expectations by +4.99%.
PRVA Stock Performance
Access detailed PRVA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
